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Background: Gastric banding is a well established
weight reduction operation that is effective in the
treatment of severe obesity. Its metabolic and
endocrine mechanisms of action, however, remain
unclear. The aim of this study was to establish a rat
model of gastric banding that would replicate the pro-
cedure performed in human obese patients.
Methods: Male Wistar rats were submitted either to
gastric banding (n=5) or sham gastric banding (n=4), and
were followed for 21 days. Detailed description on how to
perform gastric banding in rats are herein described.
Results: The Wistar rats submitted to gastric banding
showed a decrease in weight gain and food intake when
compared to sham-operated rats.The cumulative weight
gain during the 21 days after the surgical procedure was
143 ± 2.58 g for the gastric banded rats and 162 ± 2.48 g
for the sham-operated animals (P=0.001). The cumula-
tive food intake was 329 ± 0.53 g for the gastric banded
rats and 380 ± 15.22 g for the sham-operated animals,
also statistically significant (P=0.025).
Conclusion: A rat model to study gastric banding is
described. This model can now be used for experimen-
tal investigation of biochemical and molecular mecha-
nisms of weight loss resulting from this type of surgery.
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Introduction
The prevalence of obesity is accelerating worldwide.
The obesity epidemic is recognized by the World
Health Organization as one of the top 10 global health
problems.1 Obesity is associated with increased preva-
lence of hypertension, dyslipidemia, diabetes type 2,
cardiovascular disease, non-alcoholic steatohepatitis,
sleep apnea, osteoarthritis and depression.1 The high
morbidity rate is costly, both for the individual and the
health-care system.2-4 Weight loss improves or
resolves the co-morbidities.5,6
Bariatric surgery, by restrictive or malabsorptive
methods, is the only treatment sustaining weight loss.5
Gastric banding, a restrictive type of bariatric surgery,
is a well established weight reduction operation,7
although the precise mechanisms leading to weight
reduction are not fully understood.5 In general,
bariatric surgery is considered to induce weight loss
by reduction of gastric capacity and by decrease in
appetite, both leading to diminished food intake.2 If
and how such a surgical procedure interferes with
appetite and satiety is difficult to demonstrate in
humans. Thus far, there are no experimental studies to
support this interpretation. Further investigations on
the sustained weight loss that follows gastric banding
may enable a better understanding of the appetite-sati-
ety pathways, and also the development of new and
more successful medical treatments of obesity.
There is a need for an animal model that will
allow the testing of putative mechanisms whereby
surgical procedures lead to a decrease in food intake
and body weight, that are known to be regulated by
the interaction between the gastrointestinal tract and
the hypothalamus.2 We have, therefore, investigated
whether gastric banding would lead to weight loss
in Wistar rats in a way that would resemble what
occurs in the human after gastric banding. In the
current preliminary report using a small number of
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rats, we document that there are significant differ-
ences between rats submitted to gastric banding and
sham-operated controls with regards both to food
intake and body weight.
Materials and Methods
Nine male Wistar rats (125-150 g) purchased from the
commercial breeder Charles River, Barcelona, were
maintained in individual cages under controlled tem-
perature (21-23˚C), humidity, and light (12h light, 12h
dark, lights on at 0800 h) with ad libitum access to
standard rat chow (A04, Panlab, s.l., Barcelona, Spain)
and tap water. All procedures were approved by the
local Ethics Board for Animal Research, and followed
the European Union laws on animal protection
(86/609/EC). Animals were acclimatized to the local
facilities for 7 days before surgery and only healthy
growing animals were used in the experiments. 
After an overnight 12h fast, rats were anesthetized
by intra-peritoneal injection of a mixture of keta-
mine 60 mg/kg (Imalgene 1000, Merial, Portugal)
and xilazine 12 mg/kg (Rompun, Bayer, Portugal)
according to body weight. A midline abdominal
incision was made, and the stomach was exposed.
For the gastric banding, the surgical technique con-
sisted in placing a 14-mm long and 2-mm wide sil-
icone band, custom-made, at the glandular portion
of the gastric fundus immediately below the rumen,
partially restraining the stomach volume and creat-
ing upper and lower pouches in the stomach. To
keep the band from sliding and from dislocation,
two vertical stitches (Prolene 5/0, Ethicon,
Edinburgh) were placed in the anterior stomach wall
near the lesser and the greater curvatures (Figure 1A
and B). The abdominal wall was closed with re-
absorbable sutures (Vycril 3/0, Ethicon, Edinburgh). 
As controls, a sham-operated group of four rats
was included. These rats were submitted to the same
procedure described above, except for the placing of
a non-restraining band in the same location which
was removed immediately before closure of the
abdominal wall. Both groups of animals were given
5 ml sterile warmed saline subcutaneously to avoid
dehydration and allowed to recover spontaneously
from anesthesia and the surgery.
Rats were returned to their home cages which con-
tained a pre-weighed amount of food. Body weight
was measured daily at 0900 h using a scale (Monobloc,
Metterr, Toledo, Spain), recording to the nearest 1 g
and the remaining food in the hopper was reweighed at
the same time using a scale (Kern, KB 5000-1,
Balingen, Germany) recording to the nearest 0.1 g,
which allowed daily food intake to be calculated.
Results are shown as means ± SE, unless other-
wise specified. Unpaired t-test was used for com-
parison of the means between the two unpaired
treatment groups; P<0.05 was considered to be sta-
tistically significant.
Results
Male Wistar rats were submitted either to gastric
banding (n=5) or sham gastric banding (n=4), as
described above, and were followed for 21 days after
the surgical procedure. All animals submitted to sur-
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Figure 1A. Surgical placement of a gastric band around the
stomach of a Wistar rat, just below the rumen of the animal.
Figure 1B. The stomach of a Wistar rat after being submit-
ted to gastric banding.
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gery recovered successfully and survived until the
end of the experiment. Baseline mean body weight
was comparable in the two groups of animals before
treatment: gastric banded (156.6 ± 4.04 g) and sham-
operated (152.5 ± 4.87 g) rats, respectively (P=0.53). 
After surgery, gastric banded rats showed a
decrease in weight gain compared to sham-operated
animals (Figure 2). The cumulative weight gain 21
days after the procedure was 143 ± 2.58 g for the
gastric banded rats and 162 ± 2.48 g for the sham-
operated animals, a significant difference (P=0.001). 
During the first days after surgery, there was also
a decrease in food intake in gastric banded rats in
comparison to sham-operated ones. This was
reflected in the finding that the cumulative food
intake for the 21 days was 329 ± 0.53 g for the gas-
tric banded rats and  380 ± 15.22 g for the sham-
operated animals, also a significant difference
(P=0.025) (Figure 3). 
Discussion
This investigation documents that weight loss can be
reproduced in a rat model using a procedure similar
to human bariatric surgery with gastric banding that
is frequently employed in humans to treat morbid
obesity. The rat was selected as the experimental
model of bariatric surgery because it is the animal in
which the pathways involved in appetite and the gut-
brain cross-talk are better defined.8,9 The develop-
ment of gastric banding in the rat required several
stages involving the surgical skills learning curve
and experimentation of different techniques, due to
anatomical differences between the human and rat
stomach. To acquire these expertise was necessary
before satisfactory results were reached concerning
survival and effectiveness of the described method.
Because of the existence in the rat stomach of a
rumen, which has no correlate in the human stom-
ach, and also to the proximity between esophagus
and duodenum in the rat because the length of the
lesser curvature is very short, it was necessary to
adapt the surgical technique by placing the silicone
band just below the rumen, passing it through the
middle of the lesser curvature. This positioning of
the band is somewhat lower than the usual place-
ment in humans. Because of the anatomical and
dietetic differences between the two species, this
surgical strategy was elected as the one that better
corresponded to the human banded stomach. 
Because this was a pioneering attempt to establish
a new animal model, we have used a small number
of rats. Nevertheless, the numerical data revealed
significant differences both in body weight and in
cumulative food intake between rats submitted to
bariatric surgery and sham-operated controls. It
should be emphasized that in contrast to gastric
banding in humans, we have used animals with nor-
mal weight. Furthermore, because these were nor-
mal weight and growing rats, it was not expected to
observe a decrease in absolute weight but rather a
decrease in weight gain and food intake.
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Figure 2. Comparison of the mean cumulative body weight
gain between the two groups of Wistar rats: gastric banded
(black diamonds) and sham-operated controls (black
squares). Values are statistically significant (*P<0.05)
between the two experimental groups.
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Figure 3. Comparison of cumulative food intake between
gastric banded Wistar rats and sham-operated control during
the 21 days that followed surgery. Gastric banding resulted in
a statistically significant decrease in cumulative food intake.
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Clearly, two goals are to be pursued in experiments
in the near future: to reproduce these data in a larger
number of Wistar rats and to apply this model in
obese Zucker rats. These rodents, would be a better
model than the normal weight Wistar rat, because that
model could better replicate the common human obe-
sity, with respect to weight loss and improvement in
co-morbities that are observed after bariatric surgery.
In Zucker rats, obesity is due to a missense mutation
of the gene coding for the leptin receptor, diminishing
the leptin signalling in the brain, causing hyperphagia
and positive energy balance.10-12 Leptin resistance is
also found in the most common cases of human obe-
sity, for unknown reasons although considered to be
multi-factorial and polygenic in nature.13-15
In conclusion, this is the first evidence for an ani-
mal model that reproduces changes in body weight
that occur in obese humans after bariatric surgery
with gastric banding. Thus, further investigation of
endocrine and metabolic alterations associated with
surgical treatment of human obesity can be
researched using this proposed experimental model.
The authors are very grateful to Antonio Sergio, MD, a
surgical expert in human gastric banding, for the technical
advice regarding how to perform the bariatric surgery.
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